scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPCELL.1996.271.6.C1973 |
P698 | PubMed publication ID | 8997200 |
P2093 | author name string | W Wang | |
M J Merrill | |||
R T Borchardt | |||
P2860 | cites work | Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 |
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor | Q24328901 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis | Q34578752 | ||
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues | Q35596585 | ||
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. | Q35823939 | ||
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites | Q37541880 | ||
Vascular endothelial growth factor and its receptors | Q40389545 | ||
The blood-brain barrier in vitro: the second decade | Q40801005 | ||
Vascular permeability factor (VPF, VEGF) in tumor biology | Q40801255 | ||
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium | Q42477247 | ||
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 | ||
Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation | Q44770040 | ||
Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier | Q48241067 | ||
Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism | Q48356189 | ||
Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability | Q48729747 | ||
Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. | Q52486467 | ||
P433 | issue | 6 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
microvessel | Q6840468 | ||
P304 | page(s) | C1973-80 | |
P577 | publication date | 1996-12-01 | |
P1433 | published in | American Journal of Physiology | Q2160146 |
P1476 | title | Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro | |
P478 | volume | 271 |
Q36959330 | A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells |
Q48146764 | Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. |
Q33960909 | An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability |
Q28577585 | Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain |
Q36479728 | Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability |
Q92626377 | Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice |
Q50514667 | Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat. |
Q48139522 | Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice |
Q38592449 | Factors controlling permeability of the blood-brain barrier |
Q28538396 | HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway |
Q46988906 | High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes |
Q47672573 | Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells. |
Q50502412 | Investigation of vascular endothelial growth factor effects on pulmonary endothelial monolayer permeability and neutrophil transmigration. |
Q35046911 | Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation |
Q33985590 | Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? |
Q47301250 | Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size |
Q48566429 | Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control |
Q36166111 | Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. |
Q74038326 | Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro |
Q37986496 | Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors |
Q33746856 | Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs |
Q47696803 | Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia |
Q28293570 | Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice |
Q34720417 | Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention? |
Q41844840 | Simulating vasogenic brain edema using chronic VEGF infusion |
Q35064306 | The adverse effect of selective cyclooxygenase-2 inhibitor on random skin flap survival in rats |
Q52688746 | The role of VE-cadherin in blood-brain barrier integrity under central nervous system pathological conditions. |
Q37020101 | Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia |
Q40543578 | Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells |
Q30936721 | VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain |
Q43512732 | VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly |
Q28360225 | Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch |
Q73368035 | Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain |
Q33954958 | Vascular endothelial growth factors and vascular permeability |
Q28539799 | Vascular endothelial growth factors enhance the permeability of the mouse blood-brain barrier |